22 results on '"Kukreti, Vishal"'
Search Results
2. Clinical significance of clonal hematopoiesis in the setting of autologous stem cell transplantation for lymphoma
3. Risk stratification for relapsed/refractory classical Hodgkin lymphoma integrating pretransplant Deauville score and residual metabolic tumor volume
4. Kinetics of response to first‐ and second‐line therapies in multiple myeloma: Assessment by both M‐spikes and light chains
5. A descriptive cost‐analysis of MYX.1/MCRN003, a phase 2 clinical trial evaluating high‐dose weekly carfilzomib, cyclophosphamide, and dexamethasone in relapsed and refractory multiple myeloma
6. The impact of lenalidomide maintenance on second‐line chemotherapy in transplant eligible patients with multiple myeloma
7. Validation of the RHL30 digital gene expression assay as a prognostic biomarker for relapsed Hodgkin lymphoma
8. Secondary primary malignancies during the lenalidomide-dexamethasone regimen in relapsed/refractory multiple myeloma patients
9. Identifying existing Choosing Wisely recommendations of high relevance and importance to hematology
10. A pharmacokinetics and safety phase 1/1b study of oral ixazomib in patients with multiple myeloma and severe renal impairment or end‐stage renal disease requiring haemodialysis
11. Clinical characteristics and early treatment outcomes of follicular lymphoma in young adults
12. Phase I‐II trial of oral cyclophosphamide, prednisone and lenalidomide for the treatment of patients with relapsed and refractory multiple myeloma
13. Long-term survival with cyclophosphamide, bortezomib and dexamethasone induction therapy in patients with newly diagnosed multiple myeloma
14. Long-term follow-up of a phase 2 trial of single agent lenalidomide in previously untreated patients with chronic lymphocytic leukaemia
15. Autologous stem cell transplant is an effective therapy for carefully selected patients with AL amyloidosis: experience of a single institution
16. Central nervous system involvement with multiple myeloma: long term survival can be achieved with radiation, intrathecal chemotherapy, and immunomodulatory agents
17. D(T)PACE as salvage therapy for aggressive or refractory multiple myeloma
18. Efficacy of thalidomide-based therapy following lenalidomide plus dexamethasone in patients with relapsed/refractory multiple myeloma
19. Autologous stem cell transplant for light chain deposition disease: Incorporating bortezomib to the induction therapy
20. Cyclophosphamide and prednisone induction followed by cyclophosphamide mobilization effectively decreases the incidence of engraftment syndrome in patients with POEMS syndrome who undergo stem cell transplantation
21. Alkaline phosphatase variation during carfilzomib treatment is associated with best response in multiple myeloma patients
22. Two distinct syndromes of lymphoma associated AL amyloidosis: A case series and review of the literature
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.